GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4.825
Bid: 4.74
Ask: 4.825
Change: 0.005 (0.10%)
Spread: 0.085 (1.793%)
Open: 5.09
High: 5.09
Low: 4.75
Prev. Close: 4.82
SEE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Glaucoma Device at AAO

8 Nov 2007 12:34

Seeing Machines Limited08 November 2007 8 November 2007 Seeing Machines Limited ("Seeing Machines" or the "Company") TRUEFIELD ANALYZER PROMOTED AT AAO Seeing Machines (AIM: SEE), a leading developer of advanced computer basedimaging software systems, announces today that the Company will be promoting the TrueField Analyzer(R) at the American Academy of Ophthalmology (AAO) AnnualMeeting in New Orleans from November 10-13 2007. The TrueField Analyzer(R) isthe Company's revolutionary new medical device to assist doctors in detectingand managing glaucoma and other eye diseases. The AAO Annual Meeting is the largest annual event for ophthalmologists withover 30,000 attendees and 500 exhibiting companies and the perfect event toshowcase the TrueField Analyzer(R) It is also the first event the Company isattending to promote the TrueField Analyzer(R) since the United States Food andDrug Administration (FDA) granted marketing clearance for the TrueField Analyzer(R) in August 2007. Further information about the TrueField Analyzer(R) can be obtained from thewebsite: www.truefield-analyzer.com. Further information about Seeing Machinescan be obtained from the company website www.seeingmachines.com. --- ENDS --- Enquiries: Seeing Machines Limited Insinger de Beaufort Parkgreen CommunicationsNick Cerneaz, CEO Peter Ward, Chris Caldwell Justine Howarth, Erica Nelson+61 (0) 2 6125 6501 +44 (0) 20 7190 7015 +44 (0) 20 7851 7480www.seeingmachines.com Notes to editors: About Seeing Machines Seeing Machines is an award winning Technology Company which focuses on visionbased human machine interfaces. Formed in 2000 in Canberra, Australia, SeeingMachines' purpose is to commercialise its computer-vision across a range ofindustries and applications. Seeing Machines deliver advanced computer vision solutions for researches anddevelopers in human factors, transportation safety, computer human interaction,robotics, medical research and psychology. The flagship product faceLAB(R)provides an automated and contact-free gaze and head tracking technology, itsolves the problem of observing human behaviour naturally, non-intrusively andwith a high degree of accuracy and usability. Building on these unique facetracking and pupil measurement and monitoring capabilities, the TrueFieldAnalyzer(R) is new medical device to assist clinicians detect and manage eyediseases such as glaucoma. The TrueField Analyzer(R) offers a new objective method to help doctors diagnoseand manage a range of eye diseases including glaucoma, age related maculardegeneration and diabetic retinopathy. Glaucoma affects about 2-3% of thepopulation over 40 years of age and is a leading source of blindness. Unlikemost other devices available to the clinician the TrueField Analyzer is acompletely objective test and it is quick and easy for patients and techniciansalike. The device measures both eyes concurrently and due to the reliabilitythat arises from the objective nature of the test, it has the potential tobecome a new standard in the measurement of visual field defects and thus in thediagnosis and management of disease such as glaucoma. More generally Seeing Machines' computer vision systems are able to measure theorientation and position of a human head, estimate eye-gaze direction, detecteye blinks and track other facial features. This functionality is achievedentirely though visual means, using video cameras connected to advanced imageprocessing software, with no attachments required on the subject. Products suchas faceLAB(R) are designed to allow human factors researchers and designers toassess the interaction of an operator in an environment and this findsapplication in designing operator environments, such as cockpits for cars,trucks, trains, and aeroplanes for instance, and other industrial designapplications, as well as medical and psychological research situations. Thetechnology has been developed into the Driver State Sensor (DSS2) product forapplication in monitoring vehicle drivers and if it detects drowsiness (fatigue)or that the driver is distracted and their attention has been diverted from theroad, alarms are raised to alert the driver to these events. In largerdeployments, such as in fleet and mining equipment operations, the data isavailable in both real-time and off-line modes for fleet management, drivertraining and awareness programs The systems work in real-time, enabling the behaviour of subjects to be trackedin real-time. This technology is paving the way in promoting safer drivingconditions and works to enhance the driving experience and to eliminateaccidents caused through driver drowsiness or distraction. There are many different sectors that can benefit from this revolutionarysoftware, for which it has been developed, including: automotive; academicresearch; medicine/healthcare; defence; autostereoscopy (next generationdisplays); sport; and games. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th May 202011:00 amRNSPrice Monitoring Extension
5th May 20204:41 pmRNSSecond Price Monitoring Extn
5th May 20204:35 pmRNSPrice Monitoring Extension
14th Apr 20201:53 pmRNSHolding(s) in Company
9th Apr 20207:00 amRNSDirector/PDMR Shareholding
6th Apr 20204:40 pmRNSSecond Price Monitoring Extn
6th Apr 20204:35 pmRNSPrice Monitoring Extension
2nd Apr 20202:06 pmRNSSecond Price Monitoring Extn
2nd Apr 20202:00 pmRNSPrice Monitoring Extension
2nd Apr 202011:00 amRNSPrice Monitoring Extension
1st Apr 20204:40 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
1st Apr 20207:00 amRNSAutomotive License Deal
20th Mar 202011:06 amRNSSecond Price Monitoring Extn
20th Mar 202011:01 amRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 202011:05 amRNSSecond Price Monitoring Extn
17th Mar 202011:00 amRNSPrice Monitoring Extension
17th Mar 20207:00 amRNSCOVID-19 Update
16th Mar 20204:41 pmRNSSecond Price Monitoring Extn
16th Mar 20204:36 pmRNSPrice Monitoring Extension
10th Mar 20207:00 amRNSHalf year results to 31 December 2019
4th Mar 20207:00 amRNSAppointment of Joint Broker
30th Jan 20207:00 amRNSHalf year trading update
27th Jan 202010:52 amRNSHolding(s) in Company
13th Jan 20207:44 amRNSFOVIO Chip to display at Automotive World Tokyo
9th Jan 20207:00 amRNSSEE and Qualcomm Combine to Deliver DMS Technology
6th Jan 20207:00 amRNSSEE to showcase DMS technology at CES 2020
6th Jan 20207:00 amRNSFOVIO Chip optimized for NCAP readiness
16th Dec 201910:38 amRNSHolding(s) in Company
28th Nov 20198:00 amRNSResult of AGM
22nd Nov 20199:44 amRNSHolding(s) in Company
20th Nov 20199:31 amRNSUS NTSB Recommends Driver Monitoring
13th Nov 20197:00 amRNSBoard Changes - Seeing Machines Appoints New NEDs
11th Nov 20199:58 amRNSEuropean Council Adopts Enhanced Safety Regulation
8th Nov 20191:28 pmRNSHolding(s) in Company
7th Nov 20199:50 amRNSCapital Markets Day Presentation
6th Nov 20197:00 amRNSBusiness Update
30th Oct 20197:00 amRNSNotice of AGM
25th Oct 20197:00 amRNSFleet deal with North America's Safest Fleet
22nd Oct 201911:34 amRNSShare Transfer and Issue of Performance Rights
11th Oct 201912:00 pmRNSHolding(s) in Company
2nd Oct 20197:33 amRNSCollaboration with Alaska Airlines
1st Oct 201910:14 amRNSDirector/PDMR Shareholding
30th Sep 20197:00 amRNSCEO Long Term Incentive Plan
27th Sep 201911:50 amRNSHolding(s) in Company
23rd Sep 20197:00 amRNSYear End Results
19th Sep 20199:18 amRNSWebcast Presentation - Year End Results
18th Sep 20197:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.